AG

Anne Goubier

CL Cancer Research Technology Limited: 12 patents #18 of 493Top 4%
TT Tusk Therapeutics: 12 patents #1 of 12Top 9%
BL Black Belt Therapeutics Limited: 7 patents #1 of 9Top 15%
GE Genticel: 2 patents #7 of 10Top 70%
📍 Stevenage, GB: #23 of 520 inventorsTop 5%
Overall (All Time): #201,815 of 4,157,543Top 5%
21
Patents All Time

Issued Patents All Time

Showing 1–21 of 21 patents

Patent #TitleCo-InventorsDate
12343394 CD38 modulating antibody agents Pascal Merchiers, Kevin Moulder, Nina Eissler, Josephine Salimu, Simone Filosto +3 more 2025-07-01
12304964 CD38 modulating antibody Josephine Salimu, Kevin Moulder, Beatriz Goyenechea Corzo, Simone Filosto, Pascal Merchiers +3 more 2025-05-20
12161717 CD38 modulating antibody agents Pascal Merchiers, Kevin Moulder, Nina Eissler, Josephine Salimu, Simone Filosto +3 more 2024-12-10
12162949 CD38 antibody Josephine Salimu, Kevin Moulder, Beatriz Goyenechea Corzo, Simone Filosto, Pascal Merchiers +3 more 2024-12-10
11919960 Anti-CD25 antibody agents Beatriz Goyenechea Corzo, Josephine Salimu, Kevin Moulder, Pascal Merchiers, Sergio Quezada 2024-03-05
11879014 Method of treating cancer or depleting regulatory T cells in a subject by administering a human IGG1 anti-CD25 antibody Josephine Salimu, Kevin Moulder, Beatriz Goyenechea Corzo, Pascal Merchiers, Sergio Quezada +3 more 2024-01-23
11873341 Anti-CD25 for tumour specific cell depletion Beatriz Goyenechea Corzo, Josephine Salimu, Kevin Moulder, Pascal Merchiers, Sergio Quezada 2024-01-16
11851494 Anti-CD25 for tumour specific cell depletion Beatriz Goyenechea Corzo, Josephine Salimu, Kevin Moulder, Pascal Merchiers, Sergio Quezada 2023-12-26
11814434 Anti-CD25 for tumour specific cell depletion Beatriz Goyenechea Corzo, Josephine Salimu, Kevin Moulder, Pascal Merchiers, Mark Brown +3 more 2023-11-14
11802161 Anti-CD25 for tumour specific cell depletion Beatriz Goyenechea Corzo, Josephine Salimu, Kevin Moulder, Pascal Merchiers, Mark Brown +3 more 2023-10-31
11802160 Anti-CD25 antibody agents Beatriz Goyenechea Corzo, Josephine Salimu, Kevin Moulder, Pascal Merchiers, Mark Brown +3 more 2023-10-31
11787866 Anti-CD25 antibody agents Beatriz Goyenechea Corzo, Josephine Salimu, Kevin Moulder, Pascal Merchiers, Mark Brown +3 more 2023-10-17
11780930 CD38 modulating antibody Pascal Merchiers, Kevin Moulder, Nina Eissler, Josephine Salimu, Simone Filosto +3 more 2023-10-10
11697688 Anti-CD25 for tumour specific cell depletion Beatriz Goyenechea Corzo, Josephine Salimu, Kevin Moulder, Pascal Merchiers, Mark Brown +3 more 2023-07-11
11542338 CD38 modulating antibody Josephine Salimu, Kevin Moulder, Beatriz Goyenechea Corzo, Simone Filosto, Pascal Merchiers +3 more 2023-01-03
11236173 CD38 antibody Josephine Salimu, Kevin Moulder, Beatriz Goyenechea Corzo, Simone Filosto, Pascal Merchiers +3 more 2022-02-01
10752691 Anti-CD25 antibody agents Beatriz Goyenechea Corzo, Josephine Salimu, Kevin Moulder, Pascal Merchiers, Mark Brown +3 more 2020-08-25
10745485 Anti-CD25 antibody agents Beatriz Goyenechea Corzo, Josephine Salimu, Kevin Moulder, Pascal Merchiers, Mark Brown +3 more 2020-08-18
10738125 Anti-CD25 antibody agents Beatriz Goyenechea Corzo, Josephine Salimu, Kevin Moulder, Pascal Merchiers, Mark Brown +3 more 2020-08-11
9902947 CyaA-carried polypeptide(s) and use to induce both therapeutic and prophylactic immune responses Michael Esquerre, Marie Momot, Yolande Misseri 2018-02-27
9827302 HPV/CyaA-based chimeric proteins and their uses in the induction of immune responses against HPV infection and HPV-induced disorders Yolande Misseri, Philippe Bridonneau 2017-11-28